EE9900562A - Ravimimanustusvahendid ja meetodid viirus- ning mikroobsete infektsioonide ja kurnatusesündroomi raviks - Google Patents

Ravimimanustusvahendid ja meetodid viirus- ning mikroobsete infektsioonide ja kurnatusesündroomi raviks

Info

Publication number
EE9900562A
EE9900562A EEP199900562A EEP9900562A EE9900562A EE 9900562 A EE9900562 A EE 9900562A EE P199900562 A EEP199900562 A EE P199900562A EE P9900562 A EEP9900562 A EE P9900562A EE 9900562 A EE9900562 A EE 9900562A
Authority
EE
Estonia
Prior art keywords
viral
treatment
methods
drug administration
fatigue syndrome
Prior art date
Application number
EEP199900562A
Other languages
English (en)
Inventor
Olga Patricia Giesteira Visser Michelle
Original Assignee
Cryopreservation Technologies Cc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/874,425 external-priority patent/US5935597A/en
Application filed by Cryopreservation Technologies Cc filed Critical Cryopreservation Technologies Cc
Publication of EE9900562A publication Critical patent/EE9900562A/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
EEP199900562A 1997-06-13 1998-06-09 Ravimimanustusvahendid ja meetodid viirus- ning mikroobsete infektsioonide ja kurnatusesündroomi raviks EE9900562A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/874,425 US5935597A (en) 1995-12-15 1997-06-13 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
PCT/US1998/011956 WO1998056325A1 (en) 1997-06-13 1998-06-09 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes

Publications (1)

Publication Number Publication Date
EE9900562A true EE9900562A (et) 2000-06-15

Family

ID=25363728

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900562A EE9900562A (et) 1997-06-13 1998-06-09 Ravimimanustusvahendid ja meetodid viirus- ning mikroobsete infektsioonide ja kurnatusesündroomi raviks

Country Status (34)

Country Link
EP (1) EP1011567A1 (et)
JP (1) JP4531141B2 (et)
KR (1) KR20010013709A (et)
CN (1) CN1260703A (et)
AP (1) AP1629A (et)
AR (1) AR012970A1 (et)
AU (1) AU7831598A (et)
BG (1) BG103997A (et)
BR (1) BR9810095A (et)
CA (1) CA2295176A1 (et)
CZ (1) CZ298510B6 (et)
EA (1) EA200000011A1 (et)
EE (1) EE9900562A (et)
ES (1) ES2161187B1 (et)
FI (1) FI19992648A (et)
GB (1) GB2341319B (et)
HU (1) HUP0003034A2 (et)
ID (1) ID23516A (et)
IL (2) IL133396A0 (et)
IS (1) IS5289A (et)
LT (1) LT4714B (et)
LV (1) LV12490B (et)
NO (1) NO996117L (et)
NZ (1) NZ501669A (et)
OA (1) OA11307A (et)
PL (1) PL196256B1 (et)
RO (1) RO121252B1 (et)
SI (1) SI20191A (et)
SK (1) SK172299A3 (et)
TN (1) TNSN98086A1 (et)
TR (1) TR200000540T2 (et)
WO (1) WO1998056325A1 (et)
YU (1) YU66099A (et)
ZA (1) ZA984649B (et)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070212402A1 (en) * 2003-12-05 2007-09-13 Rooven Qainton V Patch

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5534260A (en) * 1989-02-23 1996-07-09 University Of Utah Percutaneous drug delivery system
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
CA2130360C (en) * 1992-02-20 1998-06-09 Allan D. Cardin Sulfonic acid derivatives in the treatment of viral diseases
AU724026B2 (en) * 1995-12-15 2000-09-07 Virodene Pharmaceutical Holdings (Pty) Ltd. Composition for organ cryopreservation and treatment of viral and bacterial infections

Also Published As

Publication number Publication date
HUP0003034A2 (hu) 2000-12-28
JP2002511862A (ja) 2002-04-16
GB2341319A (en) 2000-03-15
WO1998056325A1 (en) 1998-12-17
CA2295176A1 (en) 1998-12-17
EP1011567A4 (en) 2000-06-28
LT4714B (lt) 2000-10-25
OA11307A (en) 2003-10-24
RO121252B1 (ro) 2007-02-28
EP1011567A1 (en) 2000-06-28
JP4531141B2 (ja) 2010-08-25
ES2161187A1 (es) 2001-11-16
NZ501669A (en) 2001-09-28
YU66099A (sh) 2002-10-18
EA200000011A1 (ru) 2000-08-28
SK172299A3 (en) 2000-09-12
ZA984649B (en) 1999-12-17
IL133396A0 (en) 2001-04-30
AP9901708A0 (en) 1999-12-31
NO996117D0 (no) 1999-12-10
ID23516A (id) 2000-04-27
ES2161187B1 (es) 2003-08-16
IS5289A (is) 1999-12-08
GB9929189D0 (en) 2000-02-02
TNSN98086A1 (fr) 2005-03-15
PL338439A1 (en) 2000-11-06
LV12490A (en) 2000-06-20
FI19992648A (fi) 2000-02-03
AU7831598A (en) 1998-12-30
CZ298510B6 (cs) 2007-10-24
CZ9904473A3 (cs) 2001-03-14
CN1260703A (zh) 2000-07-19
LT99148A (en) 2000-07-25
PL196256B1 (pl) 2007-12-31
KR20010013709A (ko) 2001-02-26
AR012970A1 (es) 2000-11-22
IL133396A (en) 2006-10-05
NO996117L (no) 2000-02-11
AP1629A (en) 2006-07-11
TR200000540T2 (tr) 2000-09-21
BG103997A (en) 2001-07-31
SI20191A (sl) 2000-10-31
GB2341319B (en) 2002-02-27
LV12490B (en) 2000-12-20
BR9810095A (pt) 2001-11-13

Similar Documents

Publication Publication Date Title
DE69807634D1 (de) Medizinische einrichtung zur verabreichung von therapeutischen wirkstoffen
DE60121988D1 (de) Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DE69832298D1 (de) Gerät zur kontrollierten abgabe von pharmazeutischen und medizinischen produkten
DE60039626D1 (de) Vorrichtungen zur verabreichung von arzneistoffen mit antiprogestinischen eigenschaften
EE9900453A (et) Graanul, farmatseutiline doseerimisvorm, graanulite valmistamismeetod ja ravimiga kaetud graanulid
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
DK0956858T3 (da) Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
EE05000B1 (et) 2'-asendatud 1,1'-bifenüül-2-karboksamiidid, nende kasutamine ja farmatseutilised preparaadid
FI963883A (fi) Farmaseuttisia valmisteita ja lääkeaineita endoteelin toimintahäiriön ehkäisemiseksi ja hoitamiseksi
EE04497B1 (et) Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine
NO20003229D0 (no) Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske legemidler for behandling av proliferaktive sykdommer
NO960775D0 (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
EE04263B1 (et) Farmatseutiline kompositsioon piperidinoalkanoolantihistamiini ja selle derivaatide biosaadavuse suurendamiseks ning allergiliste reaktsioonide raviks patsiendil
FR2735475B1 (fr) Derives de n-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl) benzamide, leur preparation et leur application en therapeutique
FI973185A0 (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
EE03514B1 (et) Ühendite kombinatsioon HIV infektsiooni või AIDS-i raviks, selle kasutamine ja farmatseutiline kompositsioon
FI965114A0 (fi) Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä
EE9900562A (et) Ravimimanustusvahendid ja meetodid viirus- ning mikroobsete infektsioonide ja kurnatusesündroomi raviks
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
FR2783521B1 (fr) Derives de n-(arginyl) benzenesulfonamide, leur preparation et leur application en therapeutique
FR2756285B1 (fr) Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique
NO20013464D0 (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
DE60126067D1 (de) Maurocalcine, analoga davon und deren therapeutische anwendungen